Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 20, 2021 | Intertrust N : Why investors should check out Belgium's world-leading biotech industry | Make an enquiry The country's industrial heritage allied with strong government incentives to help it play a leading role in the race to develop Covid vaccines, say Business Development Manager Brecht Guldemont and Managing Director Christo... |
| Sep 9, 2021 | Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology |
Reviews 0
FAQ about Flamingo Therapeutics
What has the press written about Flamingo Therapeutics?
Parsers VC has collected 3 articles mentioning Flamingo Therapeutics, among them “Intertrust N : Why investors should check out Belgium's world-leading biotech industry” (Dec 20, 2021) and “Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology” (Sep 9, 2021).
Is Flamingo Therapeutics still active?
Flamingo Therapeutics is probably closed: its latest activity on Parsers VC dates from Jun 17, 2023.